Younggi Choi, Ph.D.
Deputy CSO/Head of Drug Discovery/Managing Director at Yuhan Corporation
Professional Overview
Younggi Choi, Ph.D., is an accomplished pharmaceutical R&D leader with over 15 years of experience in the drug discovery industry. As the Deputy Chief Scientific Officer, Head of Drug Discovery, and Managing Director at Yuhan Corporation, he oversees the company's central research institute and leads the synthetic drug development division, driving innovative solutions to address unmet medical needs.
Experience Summary
Current Role
As the Deputy CSO/Head of Drug Discovery/Managing Director at Yuhan Corporation, Dr. Choi is responsible for directing the company's drug discovery and development efforts. He leads a team of scientists and researchers in the identification, optimization, and advancement of novel therapeutic candidates, with a focus on leveraging cutting-edge technologies and scientific expertise to deliver innovative treatments.
Under his leadership, the drug discovery division has achieved several milestones, including the successful progression of multiple drug candidates into clinical trials and the establishment of strategic partnerships with leading global pharmaceutical companies.
Career Progression
Prior to his current role, Dr. Choi held positions of increasing responsibility at several prominent biopharmaceutical companies. He served as a Director, Research Fellow, and Principal Scientist at Alkermes, where he contributed to the development of novel drug delivery technologies and therapeutic programs. Earlier in his career, he held roles as a Principal Scientist at FORMA Therapeutics and Boehringer Ingelheim, where he played a pivotal role in advancing small molecule drug candidates through the discovery and development pipeline.
Dr. Choi's diverse experience and deep scientific expertise have been instrumental in driving the success of the projects he has been involved with, resulting in the advancement of multiple drug candidates into clinical trials and the establishment of valuable industry partnerships.
Academic Background
Dr. Younggi Choi holds a Ph.D. in Organic Chemistry from the Scripps Research Institute, where he conducted groundbreaking research in the field of synthetic organic chemistry and drug discovery. His academic achievements and specialized knowledge in medicinal chemistry and drug design have been instrumental in shaping his successful career in the pharmaceutical industry.
Areas of Expertise
- Drug discovery and development
- Medicinal chemistry and organic synthesis
- Pharmaceutical R&D strategy and leadership
- Preclinical and early-stage clinical development
- Collaboration and partnership management
- Scientific innovation and technology integration
Professional Impact
Under Dr. Choi's leadership, the drug discovery division at Yuhan Corporation has achieved significant milestones, including the advancement of several novel drug candidates into clinical trials and the establishment of strategic partnerships with leading global pharmaceutical companies. His expertise in medicinal chemistry, drug design, and R&D management has been crucial in driving the company's success and advancing the development of innovative treatments to address unmet medical needs.
Conclusion
With his extensive experience, proven track record of success, and deep scientific expertise, Dr. Younggi Choi is a highly respected pharmaceutical R&D leader. In his current role as the Deputy CSO, Head of Drug Discovery, and Managing Director at Yuhan Corporation, he continues to spearhead the company's drug discovery and development efforts, positioning it as a leader in the industry and making a meaningful impact on the lives of patients worldwide.
